Sale disclosed
Theodore Alan Huizenga
SVP, Chief Accounting Officer
Common Stock
- Reported value
- $17.41K
- Reported price
- $13.57 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Ultragenyx Pharmaceutical Inc.
Last 30 daysNo qualifying insider buying. Sales: $17.41K by 1 insider.
Showing the first 6 of 42 trades on this page.
SVP, Chief Accounting Officer
Common Stock
SVP, Chief Accounting Officer
Common Stock
EVP and Chief Legal Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Director
Common Stock
EVP and Chief Legal Officer
Common Stock
Chief Financial Officer
Common Stock
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP and Chief Medical Officer
Common Stock
Chief Financial Officer
Common Stock
SVP, Chief Accounting Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP, Chief Accounting Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President & CEO
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President & CEO
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
See Remarks
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
See Remarks
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
See Remarks
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
See Remarks
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP and Chief Legal Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP and Chief Legal Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP & Chief Commercial Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP & Chief Commercial Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP and Chief Medical Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP and Chief Medical Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Financial Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Financial Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Financial Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| SVP, Chief Accounting Officer | Common StockSale10b5-1 | 1,283$13.57 / share | $17.41K | Sep 15Filed Sep 15 · 0d later | SEC filing |
| SVP, Chief Accounting Officer | Common StockSale | 161$13.99 / share | $2.25K | Sep 3Filed Sep 8 · 5d later | SEC filing |
| EVP and Chief Legal Officer | Common StockSale10b5-1 | 1,900$24.92 / share | $47.35K | Aug 3Filed Aug 4 · 1d later | SEC filing |
| Chief Financial Officer | Common StockSale10b5-1 | 4,696$24.92 / share | $117.02K | Aug 3Filed Aug 4 · 1d later | SEC filing |
| Chief Financial Officer | Common StockSale10b5-1 | 4,698$33.13 / share | $155.64K | Jul 1Filed Jul 6 · 5d later | SEC filing |
| Director | Common StockSale | 2,000$25.05 / share | $50.1K | Jun 15Filed Jun 15 · 0d later | SEC filing |
| EVP and Chief Legal Officer | Common StockSale10b5-1 | 1,899$24.62 / share | $46.75K | Jun 15Filed Jun 15 · 0d later | SEC filing |
| Chief Financial Officer | Common StockSale10b5-1 | 4,653$23.77 / share | $110.6K | Jun 1Filed Jun 1 · 0d later | SEC filing |
| Director | Common StockGrant or award | 7,751Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units14,058Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Common StockGrant or award10b5-1 | 7,751Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Common StockSale10b5-1 | 5,740$25.12 / share | $144.19K | May 18Filed May 18 · 0d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award10b5-1 | Derivative units14,058Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Common StockGrant or award | 7,751Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units14,058Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Common StockGrant or award | 7,751Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units14,058Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Common StockGrant or award | 7,751Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units14,058Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Common StockGrant or award | 7,751Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units14,058Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Common StockGrant or award | 7,751Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units14,058Award · no purchase price | Non-cash award | May 14Filed May 18 · 4d later | SEC filing |
| EVP and Chief Medical Officer | Common StockSale | 344$24.96 / share | $8.59K | May 5Filed May 6 · 1d later | SEC filing |
| Chief Financial Officer | Common StockSale10b5-1 | 4,683$24.90 / share | $116.61K | May 1Filed May 4 · 3d later | SEC filing |
| SVP, Chief Accounting Officer | Common StockGrant or award | 20,241Award · no purchase price | Non-cash award | Apr 22Filed Apr 24 · 2d later | SEC filing |
| SVP, Chief Accounting Officer | Stock Option (Right to Buy)Grant or award | Derivative units7,348Award · no purchase price | Non-cash award | Apr 22Filed Apr 24 · 2d later | SEC filing |
| President & CEO | Common StockGrant or award | 76,745Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| President & CEO | Stock Option (Right to Buy)Grant or award | Derivative units132,693Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| See Remarks | Common StockGrant or award | 23,116Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| See Remarks | Stock Option (Right to Buy)Grant or award | Derivative units79,936Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| See Remarks | Common StockGrant or award | 23,116Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| See Remarks | Stock Option (Right to Buy)Grant or award | Derivative units79,936Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| EVP and Chief Legal Officer | Common StockGrant or award | 28,895Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| EVP and Chief Legal Officer | Stock Option (Right to Buy)Grant or award | Derivative units49,960Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| EVP & Chief Commercial Officer | Common StockGrant or award | 28,895Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| EVP & Chief Commercial Officer | Stock Option (Right to Buy)Grant or award | Derivative units49,960Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| EVP and Chief Medical Officer | Common StockGrant or award | 34,674Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| EVP and Chief Medical Officer | Stock Option (Right to Buy)Grant or award | Derivative units59,952Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| Chief Financial Officer | Common StockGrant or award | 34,674Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| Chief Financial Officer | Stock Option (Right to Buy)Grant or award | Derivative units59,952Award · no purchase price | Non-cash award | Apr 16Filed Apr 20 · 4d later | SEC filing |
| Chief Financial Officer | Common StockSale10b5-1 | 4,683$20.97 / share | $98.2K | Apr 1Filed Apr 2 · 1d later | SEC filing |
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberUltragenyx Pharmaceutical Inc. - Common Stock (RARE) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House member